30% Of Acquisition Price Paid If Venom Revenues Hit $30,000,000 and $40,000,000 By DEC 31, 2021
Average revenue per gram YTD 2019 $CDN 14 and will continue to increase as vape cartridge mix grows ($CDN 30 per gram)
One Of Arizona’s Largest Producers Of Award-Winning Medical Cannabis Distillate
Acquisition Expected To Close By March 31, 2020 Subject To Due Diligence
An established brand in Arizona for high quality
products in the wholesale and distillate marketplace. Venom is
leveraging its brand and success to aggressively expand into other US
states.
ACQUISITION TERMS
Hollister will acquire Venom Extracts for CDN$20,000,000 via Hollister stock
The stock price will be determined based on the greater of:
The 14-day VWAP (Volume Weighted Average Price) capped at $0.25 subsequent to announcing the transaction and $0.20
Once share price is established, 70% of the Payment Shares will be issued upon closing of the transaction
Remaining
30% of the Payment Shares will be issued when and if the following
milestones have been met on or prior to December 31st, 2021
Posted by AGORACOM-JC
at 3:29 PM on Thursday, February 27th, 2020
Announced the launch of its redesigned website taking effect this March
Website has been revamped to include new features and improved functionality that provide instant access to essential information and features geared towards PyroGenesis’ interested partiesÂ
MONTREAL, Feb. 27, 2020 — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX-V: PYR) (OTCQB: PYRNF) (FRA: 8PY), a high-tech company, (the “Company”, the “Corporation†or “PyroGenesis”) that designs, develops, manufactures and commercializes plasma atomized metal powder, plasma waste-to-energy systems and plasma torch products, is proud to announce the launch of its redesigned website taking effect this March. The website has been revamped to include new features and improved functionality that provide instant access to essential information and features geared towards PyroGenesis’ interested parties. Â
PyroGenesis’ new website will be continuously updated with business
developments, events, company presentations, media mentions and press
releases. Once launched, visitors are encouraged to explore the website
and sign up for direct emails from the Company.
“We are happy to unveil our redesigned website which offers a clean
and modern design providing a more comprehensive understanding of
PyroGenesis’ technologies,” said Mr. P Peter Pascali, CEO and President
of PyroGenesis. “We believe that this website will allow our visitors to
have a very informative experience as we continue to grow and increase
our market presence. I trust the timing of this news release is not lost
on our readers.â€
Of note, it is possible that, during this transition, PyroGenesis’
website may be under maintenance for a period up to 24 hours. It is also
important to note that, during the weeks following the launch date, the
redesigned website may be experiencing some minor technical
adjustments. PyroGenesis’ team will work diligently to ensure all issues
are resolved in a timely manner. The company looks forward to hearing
your comments and feedback.
About PyroGenesis Canada Inc.
PyroGenesis Canada Inc., a high-tech company, is the world leader in
the design, development, manufacture and commercialization of advanced
plasma processes and products. We provide engineering and manufacturing
expertise, cutting-edge contract research, as well as turnkey process
equipment packages to the defense, metallurgical, mining, advanced
materials (including 3D printing), oil & gas, and environmental
industries. With a team of experienced engineers, scientists and
technicians working out of our Montreal office and our 3,800 m2
manufacturing facility, PyroGenesis maintains its competitive advantage
by remaining at the forefront of technology development and
commercialization. Our core competencies allow PyroGenesis to lead the
way in providing innovative plasma torches, plasma waste processes,
high-temperature metallurgical processes, and engineering services to
the global marketplace. Our operations are ISO 9001:2015 and AS9100D
certified, and have been since 1997. PyroGenesis is a publicly-traded
Canadian Corporation on the TSX Venture Exchange (Ticker Symbol: PYR)
and on the OTCQB Marketplace. For more information, please visit www.pyrogenesis.com
This press release contains certain forward-looking statements,
including, without limitation, statements containing the words “may”,
“plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”,
“expect”, “in the process” and other similar expressions which
constitute “forward- looking information” within the meaning of
applicable securities laws. Forward-looking statements reflect the
Corporation’s current expectation and assumptions and are subject to a
number of risks and uncertainties that could cause actual results to
differ materially from those anticipated. These forward-looking
statements involve risks and uncertainties including, but not limited
to, our expectations regarding the acceptance of our products by the
market, our strategy to develop new products and enhance the
capabilities of existing products, our strategy with respect to research
and development, the impact of competitive products and pricing, new
product development, and uncertainties related to the regulatory
approval process. Such statements reflect the current views of the
Corporation with respect to future events and are subject to certain
risks and uncertainties and other risks detailed from
time-to-time in the Corporation’s ongoing filings with the securities
regulatory authorities, which filings can be found at www.sedar.com, or at www.otcmarkets.com.
Actual results, events, and performance may differ materially. Readers
are cautioned not to place undue reliance on these forward-looking
statements. The Corporation undertakes no obligation to publicly update
or revise any forward- looking statements either as a result of new
information, future events or otherwise, except as required by
applicable securities laws. Neither the TSX Venture Exchange, its
Regulation Services Provider (as that term is defined in the policies of
the TSX Venture Exchange) nor the OTCQB accepts responsibility for the
adequacy or accuracy of this press release.
SOURCE PyroGenesis Canada Inc.
For further information please contact:
Rodayna Kafal, Vice President Investors Relations and Strategic Business Development Phone: (514) 937-0002, E-mail: [email protected]
Proprietary technology platforms including Electronic Health Records portal and e-Commerce for CBD product distribution
Recently launched CBD extraction facility
First extraction system capacity = 2,300 Kg per year.
CBD based products are poised to be a $20B global industry by 2022
Medical cannabis is poised to be a $100B global industry by 2025
Company to Create Psilocybin and Psychadelics Division Leveraging Corporate Wellness Clinics and Franchise Clinic Network
CBD consumption to rise across the treatment of neurological conditions
Research shows that CBD consumption for the treatment of neurological conditions is set to rise.
With an exponential rise in the availability of CBD products and public opinion towards it becoming more positive over the past decade, the consumption of the ingredient has exploded.
Global Market Insights, Inc., forecasts that global cannabidiol market size will be worth more than $89bn by 2026.
However, the industry will need to overcome the complex regulatory
landscape as well as quality and supply challenges in the near future.
Over the past few years, cannabidiol, or CBD, has caught the public’s
imagination as an ingredient presenting a range of health benefits when
infused in various consumables. More and more individuals worldwide are
now vouching for its effectiveness in terms of alleviating certain
chronic illnesses and treating several health conditions.
CBD has conquered industry after industry, from pharmaceuticals to
personal care and cosmetics, food and beverages, and nutraceuticals.
Cannabidiol is the legal and non-psychoactive counterpart of
tetrahydro cannabidiol (THC), the chemical compound responsible for
cannabis’s psychological effects. CBD is the second most-commonly used
active ingredients of cannabis.
The cannabinoid is derived directly from the hemp plant, a cousin of
the cannabis plant, and forms an essential component of medical
cannabis.
CBD regulatory landscape in Europe
Factors such as population growth, nationalised healthcare, GDP, and
cultural historic use of CBD in many European countries make the
continent an attractive market for global producers of both medical and
retail cannabis-based products. Hemp cultivation in the region has
witnessed a massive upsurge in recent years; the European Union (EU)
constitutes more than 25% of the global hemp production.
In July last year Epidiolex CBD oil
received a positive recommendation for marketing approval from the
European Medicines Agency (EMA) for the treatment of seizures. EMA’s
Human Medicines Committee (CHMP) approved the oral solution for use with
clobazam for the treatment of seizures associated with Dravet syndrome
or Lennox-Gastaut syndrome in patients aged two or more.
The European Commission granted marketing approval to Epidyolex, the
trade name for Epidiolex in Europe, in September 2019. Epidiolex is the
only federally-approved CBD product in the U.S.
Additionally, the use of CBD in cosmetics is harmonised within the European Cosmetic Regulation 1223/2009.
The regulation prohibits the use of cannabis and its derivatives in
cosmetic products. Essentially, EU prohibits the use of CBD derived
naturally from cannabis plants. However, the use of hemp-derived or
synthetically-produced cannabidiol is approved.
Europe CBD market is poised to witness monumental growth in the
forthcoming years on account of surging consumer demand for
safe-strength CBD products that are easily available in their normal
retail environments and cultivated, extracted, processed and labelled as
per the European standards.
Growing burden of neurological diseases in Europe
Europe has witnessed a growing occurrence of various neurological
conditions in recent years. These include epilepsy, migraine, stress,
anxiety, and numerous sleeping disorders. An expanding geriatric
population base indicates rising incidences of these conditions. Citing
data from the European Brain Council, more than 220 million people in Europe
suffer from at least one neurological condition, which is more than the
populations of France, Germany, and the Great Britain combined.
Described below are some of the most prevalent neurological
conditions in Europe and the effectiveness of CBD in their treatment.
Stress and anxiety – Nearly 25% of the European population suffers
from stress, anxiety or depression each year. The effectiveness of CBD
products as anti-anxiety nutraceuticals is backed with plenty of
research, however there is still a long way to go. Several clinical
trials have provided considerable evidence of cannabidiol’s usefulness
for the treatment of generalised anxiety disorder (GAD), post-traumatic
stress disorder (PTSD), obsessive-compulsive disorder (OCD), social
anxiety disorder, and panic disorder;
Migraine – Migraine currently affects more than 11% of the global
population. The social societal burden of migraine in Europe is an
approximately €27bn
per year. While pain medications are known to help temporarily
alleviate the symptoms of migraine, they can have several side-effects.
Research concerning the use of cannabidiol for migraine is limited
however a number of laboratory studies suggest that CBD oil may help
reduce all types of acute and chronic pain, including migraine; and
Seizures – In Europe, close to six. million people suffer from
epilepsy, while 15 million people will have at least one seizure at some
point during their lifetime. Numerous research studies over the years
have demonstrated the benefits and effectiveness of hemp-derived CBD
products in patients with epilepsy who have not responded to traditional
treatment.
Surging popularity of cannabidiol among boomers along with ongoing
research and development into its potential health benefits will augment
CBD market forecast. More and more boomers are adding CBD to their
health regimes to help reduce stress and anxiety, get better sleep, and
alleviate chronic pain. Increasing awareness towards the safety and
efficacy of cannabidiol products will drive future CBD industry trends.
Posted by AGORACOM-JC
at 9:18 AM on Thursday, February 27th, 2020
KABN Systems North America Inc. A Fintech platform focused on Verifying, Managing & Monetizing Online Identity. KABN’s mission is to create a world-class suite of products and services that support the decentralized market economy, globally enabling consumers to manage their digital identity and other data to create value-based relationships in the financial and loyalty services arena.
FROM THE DESK OF DAVID LUCATCH, President, Co-Founder & Director :
Good Morning.
The Management Information Circular for the Business Combination
(RTO) between KABN Systems North America Inc. and Torino Power Solutions
Inc. (CSE:TPS) has been publicly filed on SEDAR.
Torino Power Solution’s Annual and Special Meeting is scheduled to be held on March 31, 2020 at 10 am PST in Vancouver.
To view the Management Information Circular, Please visit:
Click on View This Company’s Documents at the bottom left
Select: Management information circular – English
Dated: February 26, 2020
Click on the item and enter the code and view.
Happy Reading and feel free to share!
In addition to accelerating KABN NA’s business activities, during
this period, we will be working with the investment community and
counsel to finalize the Listing Statement for the CSE.
KABN NA will be at FFCON20 – RISE
Don’t forget to get your ticket and visit us at the 6th Annual
FFCON20 on March 23rd and 24th in Toronto – click here for your discount
tickets https://bit.ly/2Pj64UZ
As always, if you have any questions or comments, please feel free to reach out.
Posted by AGORACOM-JC
at 4:21 PM on Wednesday, February 26th, 2020
If you are a small cap CEO, Director or Investor Relations Officer in North America, my 23 minute interview with James Black of the Canadian Securities Exchange (CSE) is the most important podcast you will listen to in 2020. Not because I am the guest but because of what I have to say.
Why does what I say matter? AGORACOM surpassed 600 million page
views this year, we’re averaging over 4.5M views per month on Twitter
and we’ve served over 300 clients. As such, the powerful information
in this podcast comes from a deep understanding of both social media,
why small cap companies are failing at it and what the serious
implications are of that failure.
Make no mistake about it, this isn’t some generic social media
discussion. James and I go deep and I hit hard because that is what
good friends do. I’m sounding the alarm because of the massive
implications if I don’t.
The good news is that, if you are not an AGORACOM client, you can
turn this ship around but you have to do it now and that can only be
done by understanding why small caps are failing today.
I suggest that your entire management team listens to it and discusses it. Then let’s have a call to discuss what can be done.
The beauty of this audio format is you can listen to it at work or in
your car / subway to and from work. I’ve done the hard work
presenting this powerful information, all you have to do is press play.
Thank-you and I look forward to discussing this with you and
potentially working together in 2020. Our cashless and fully compliant
shares for services program should make the decision an easy one.
Posted by AGORACOM-JC
at 1:23 PM on Wednesday, February 26th, 2020
Announced today that, further to its press release dated October 9th, 2019, the payment terms noted therein have been adjusted pro rata to mirror Drosrite International LLC’s cash flow as outlined in their press release1 dated January 27th, 2020.Â
“With this announcement, I am happy to also report that it seems all impediments to the payment process have been addressed,†said Mr. P. Peter Pascali, President and CEO of PyroGenesis. “We look forward to having the DROSRITE™ technology installed in one of the premier facilities in the world.â€
MONTREAL, Feb. 26, 2020 — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX-V: PYR) (OTCQB: PYRNF) (FRA: 8PY), a high-tech company, (the “Company”, the “Corporation†or “PyroGenesis”) that designs, develops, manufactures and commercializes plasma atomized metal powder, plasma waste-to-energy systems and plasma torch products, announces today that, further to its press release dated October 9th, 2019, the payment terms noted therein have been adjusted pro rata to mirror Drosrite International LLC’s (“DI†or the “Clientâ€) cash flow as outlined in their press release1 dated January 27th, 2020.Â
“With this announcement, I am happy to also report that it seems all
impediments to the payment process have been addressed,†said Mr. P.
Peter Pascali, President and CEO of PyroGenesis. “We look forward to
having the DROSRITE™ technology installed in one of the premier
facilities in the world.â€
DI is a US based private company duly constituted and existing under
the laws of the State of Delaware, providing state-of-the-art waste
management technologies to the aluminum industry. DI is duly licensed by
PyroGenesis to manufacture, market, sell and distribute DROSRITE™
systems and technology to the Kingdom of Saudi Arabia, and certain other
countries in the Middle East, on an exclusive basis. All DROSRITE™
systems supplied by DI are manufactured in the USA.
About PyroGenesis Canada Inc.
PyroGenesis Canada Inc., a high-tech company, is the world leader in
the design, development, manufacture and commercialization of advanced
plasma processes and products. We provide engineering and manufacturing
expertise, cutting-edge contract research, as well as turnkey process
equipment packages to the defense, metallurgical, mining, advanced
materials (including 3D printing), oil & gas, and environmental
industries. With a team of experienced engineers, scientists and
technicians working out of our Montreal office and our 3,800 m2
manufacturing facility, PyroGenesis maintains its competitive advantage
by remaining at the forefront of technology development and
commercialization. Our core competencies allow PyroGenesis to lead the
way in providing innovative plasma torches, plasma waste processes,
high-temperature metallurgical processes, and engineering services to
the global marketplace. Our operations are ISO 9001:2015 and AS9100D
certified, and have been since 1997. PyroGenesis is a publicly-traded
Canadian Corporation on the TSX Venture Exchange (Ticker Symbol: PYR)
and on the OTCQB Marketplace. For more information, please visit www.pyrogenesis.com
This press release contains certain forward-looking statements,
including, without limitation, statements containing the words “may”,
“plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”,
“expect”, “in the process” and other similar expressions which
constitute “forward- looking information” within the meaning of
applicable securities laws. Forward-looking statements reflect the
Corporation’s current expectation and assumptions and are subject to a
number of risks and uncertainties that could cause actual results to
differ materially from those anticipated. These forward-looking
statements involve risks and uncertainties including, but not limited
to, our expectations regarding the acceptance of our products by the
market, our strategy to develop new products and enhance the
capabilities of existing products, our strategy with respect to research
and development, the impact of competitive products and pricing, new
product development, and uncertainties related to the regulatory
approval process. Such statements reflect the current views of the
Corporation with respect to future events and are subject to certain
risks and uncertainties and other risks detailed from
time-to-time in the Corporation’s ongoing filings with the securities
regulatory authorities, which filings can be found at www.sedar.com, or at www.otcmarkets.com. Actual
results, events, and performance may differ materially. Readers are
cautioned not to place undue reliance on these forward-looking
statements. The Corporation undertakes no obligation to publicly update
or revise any forward- looking statements either as a result of new
information, future events or otherwise, except as required by
applicable securities laws. Neither the TSX Venture Exchange, its
Regulation Services Provider (as that term is defined in the policies of
the TSX Venture Exchange) nor the OTCQB accepts responsibility for the
adequacy or accuracy of this press release.
SOURCE PyroGenesis Canada Inc.
For further information please contact:
Rodayna Kafal, Vice President Investors Relations and Strategic Business Development Phone: (514) 937-0002, E-mail: [email protected]
Rockville, MD—U.S. retail sales of cannabis and
cannabidiol (CBD) products reached $14 billion in 2019, and are on pace
to increase 18% per year to $33 billion in 2024, according to data
published in a new report from Packaged Facts titled Cannabis and CBD: U.S. Retail Market Trends and Opportunities.
The most common delivery format for cannabis, the flower—smoked as
buds or as cigarettes—accounts for nearly 40% of retail sales, according
to a press release. Vaporizer cartridges with concentrated THC or CBD
compounds takes the second largest share, but it’s falling, as concerns
about vaping-related lung illnesses rise. Edibles and topicals are
predicted to rise, and to rise quickly, as they stand to benefit the
most from legalization of hemp-based CBD; major retailers are already
offering CBD-infused food and beverages, as well as CBD-infused
cosmetics.
The report analyzes cannabis and cannabis-related retail trends and
opportunities in the U.S., with a focus on multi-state cannabis
dispensary operators and food and beverage introductions, as well as
market trends by state. It also includes a detailed analysis of
cannabis-related legal and regulatory trends at the federal and state
levels. The report can be purchased here.
BREAKING: Signed $20,000,000 Letter of Intent To Acquire Venom Extracts (“Venomâ€)
HIGHLY ACCRETIVE $20,000,000 ACQUISITION
Venom Highlights
2019 Est Revenue ~C$16.4M; EBITDA ~C$2.48M
30% Of Acquisition Price Paid If Venom Revenues Hit $30,000,000 and $40,000,000 By DEC 31, 2021
Average revenue per gram YTD 2019 $CDN 14 and will continue to increase as vape cartridge mix grows ($CDN 30 per gram)
One Of Arizona’s Largest Producers Of Award-Winning Medical Cannabis Distillate
Acquisition Expected To Close By March 31, 2020 Subject To Due Dilligence
An established brand in Arizona for high quality
products in the wholesale and distillate marketplace. Venom is
leveraging its brand and success to aggressively expand into other US
states.
ACQUISITION TERMS
Hollister will acquire Venom Extracts for CDN$20,000,000 via Hollister stock
The stock price will be determined based on the greater of:
The 14-day VWAP (Volume Weighted Average Price) capped at $0.25 subsequent to announcing the transaction and $0.20
Once share price is established, 70% of the Payment Shares will be issued upon closing of the transaction
Remaining
30% of the Payment Shares will be issued when and if the following
milestones have been met on or prior to December 31st, 2021
Hollister Highlights Of Current Operations:
Hollister’s products are now present in 220 of 600 California dispensaries.
Vision is to capitalize on this success to become the sought after
premium brand portfolio of Cannabis across multiple states and Hemp
nationwide
Major LOI, Joint Ventures and Licensing Agreements Support Proof Of This Vision
“Easy Riders” – Milliions Of Global Followers
“Tactical Relief” – Veteran Founded, Hemp Based CBD Brand With Nation Wide Members
“Tommy Chong” – Exclusive Manufacture & Distribution Of Tommy Chong’s Cannabis (TM) Full Spectrum Elixir 1:1
“I only partner with the best-in-class companies and I am really
pleased to have the Hollister Cannabis Co. bring their amazing Tommy
Chong’s Cannabis™ Full Spectrum Elixir to the market for me”.
– Tommy Chong
KEY JOINT VENTURES AND PARTNERSHIPS DETAILS
LOI for a proposed offtake agreement with Mountain Financial Solutions LLC
Hollister will purchase 1,000 pounds of hemp from Mountain Financial
(unique high CBD hemp strains ) for use in various smokable hemp
products – specifically, Rebel Hemp Company’s premium hemp pre-rolls.
Licensing agreement with Tommy Chong to manufacture and distribute Tommy Chong’s Cannabis™
Full Spectrum Elixir 1:1.
The tincture, features a 1:1 ratio of THC to CBD, recognized for its medicinal properties
Distributed exclusively by Indus and is anticipated to be in-dispensaries throughout California by March 01, 2020.
Anticipating producing up to 25,000 units of during the 1st 12 months with an estimated retail price of $70 per unit
LOI with ER71 USA Inc. (“Easyriders”) an iconic brand with millions of followers globally, have entered into LOI to complete a joint venture agreement
Upon completion of the Joint Venture, Hollister and Easyriders will
collaborate on the development and marketing of co-branded hemp based
everyday premium product lines.
Pre-rolled products using hemp
JV will further explore the development and marketing of additional product SKU’s for hemp-based
Edibles
Vapes
Topicals
beverages.
Revenue generated on the co-branded product lines will be shared 50:50 between Easyriders and Hollister.
Hollister Biosciences Inc. and Veteran Based Tactical Relief Enter into Letter of Intent for Proposed Joint Venture Agreement
Upon completion of the Agreement, Hollister and Tactical Relief will collaborate on the development and marketing of cannabis tinctures throughout the California market
Branded under Tactical Relief, the first cannabis tincture to be
manufactured will feature a 20:1 ratio of THC to CBD, recognized for its
medicinal properties in treating PTSD
Will be distributed exclusively by Hollister’s distribution partner, Indus Holdings Inc.
Hollister Currently Manufactures The Following Products:
hash
hash infused products
tinctures
crumble infused products
Pre-rolls
Vape Products
Pet CBD
Cannabis Concentrate
Brewed Hemp Beverages
Premium Hemp Pre-Rolls
other cannabis products
HashBones
Hashbones are a pre-roll made from 75% cannabis flower blended in small batches with 25% bubble hash
Results in a more potent pre-roll, also maintains the integrity of the cannabis
Terpenes are preserved in the bubble hash production process
Bubble hash is made without solvents or chemicals and is one of the cleanest concentrates available on the market
Hollister’s trusted and highly rated brand of pre-rolls, sold via third-party retailers
Mighty Meds
Acquired Mighty Meds as its vape brand
Company’s vape products are manufactured from pure THC distillate
and plant-based terpenes and do not use any additives that have been
linked to health issues.
San Diego based
Produces discreet, disposable, health conscious vape cartridges and other products
Purity Petibles
Purity Petibles 20:1 CBD pet tincture is manufactured using full
spectrum CBD, organic MCT Oil derived from coconuts and chicken flavor
The MCT Oil and chicken flavor used in Purity Petibles is food grade
Rebel Tea
Brewed with high-quality, American-grown
hemp and containing fifteen milligrams of whole-plant full-spectrum
phytocannabinoids, Rebel Tea offers consumers a refreshing THC-free
beverage. Rebel Tea’s innovative formula features exclusively organic
ingredients paired with light flavoring from natural lemon and cane
sugar.
NanoPure
NanoPure, nano-emulsified cannabis concentrate which will be sold both:
Wholesale as an ingredient for other companies and
power products for Hollister Cannabis Co.
DISTRIBUTION
Hollister has an exclusive distribution agreement in place with Indus Holdings (CSE: INDS).
Indus is the licensed California distributor that operates the WAYV platform.
Indus currently manages all of Hollister’s product fulfilment
obligations, allowing Hollister to focus its efforts on production and
marketing.
Indus provides Hollister with full brand representation by utilizing
its 15 sales reps to represent Hollister’s product to the California
marketplace.
Through Indus, Hollister’s products are now present in 220 dispensaries throughout California.
US CANNABIS MARKET STATS
CALIFORNIA CANNABIS MARKET STATS
HEMP
The Company intends to move into the hemp market. While cannabis is
still restricted by state regulations, CBD is not. We plan on leveraging
the brand by distributing hemp and CBD versions of our products
nationwide. We will strive to have the Rebel Hemp Co brand touch every
corner of the country.
CORPORATE STRUCTURE
Hollister develops quality branded cannabinoid-based and hemp-based
consumer goods and products for large-scale distribution through two
companies: Hollister Cannabis Co. and Rebel Hemp Company.
Posted by AGORACOM-JC
at 5:20 PM on Tuesday, February 25th, 2020
SPONSOR: CardioComm Solutions (EKG: TSX-V)
– The heartbeat of cardiovascular medicine and telemedicine. Patented
systems enable medical professionals, patients, and other healthcare
professionals, clinics, hospitals and call centres to access and manage
patient information in a secure and reliable environment.
Apple, J&J Launch New mHealth Study Targeting Wearables and AFib
Apple is partnering with Johnson & Johnson on a new mHealth study to determine whether the Apple Watch and an accompanying app can help reduce the risk of stroke in older Americans.
The Heartline Study is open to the more than 40 million seniors enrolled in Medicare
Goal is to determine whether the ECG sensor and app on the Apple Watch can accurately detect the presence of atrial fibrillation, a key indicator of stroke susceptibility.
The Heartline Study
is open to the more than 40 million seniors enrolled in Medicare. Its
goal is to determine whether the ECG sensor and app on the Apple Watch
can accurately detect the presence of atrial fibrillation, a key
indicator of stroke susceptibility.
“Right now, we rely on symptoms – such as quivering, fluttering or
irregular heart rhythm – to detect AFib,†Michael Gibson, MD, CEO of the
Baim Institute for Clinical Research, founder of the Perfuse Study
Group at Harvard Medical School and a co-leader on the study, said in a story on the J&J website.
“But the hope is that a wearable device could detect an irregular heart
rhythm earlier, since people may not be able to recognize symptoms
without assistance. It could act like a warning light that allows a
mechanic to detect whether something’s wrong before the car actually
breaks down.â€
Gibson will head the study alongside John Spertus, MD, the Daniel J.
Lauer/Missouri Endowed Chair in Metabolic and Vascular Disease Research
at the University of Missouri at Kansas City.
This study follows on the heels of the Apple Heart Study,
to date the largest analysis of mHealth data from a wearable device.
Launched in 2017 by the Stanford University School of Medicine, Apple
and American Well, the study attracted almost 420,000 participants and
laid the groundwork for the viability of ECG sensors for detecting AFib.
“The study’s findings will help patients and clinicians understand
how devices like Apple Watch can play a role in identifying atrial
fibrillation, a deadly and often undiagnosed disease,†Mintu Turakhia,
MD, an associate professor of cardiovascular medicine at Stanford, said
when the study’s results were released in 2019. “Additionally, these
important findings lay the foundation for further research into the use
of emerging wearable technologies in clinical practice and demonstrate
the unique potential of large-scale app-based studies.â€
But that study raised concerns because it wasn’t focused on one
particular population, leading to worries that such digital health tools
could cause more harm than good.
This time around, investigators are homing in on a population facing a significant risk of stroke.
“Each year more than 795,000 people have a stroke in the US, and
some studies have shown that many people would rather die than live with
the aftereffects of a disabling stroke,†Gibson said. “Secondly, we
have an aging population, so there are more and more older patients
around the world. These are exactly the patients who are at the highest
risk of atrial fibrillation, which is associated with a significant
increase in the risk of stroke. But the good news is that these strokes
may be preventable.â€
‘By having the study focus on the highest risk patients, my hope is
that we can potentially help participants improve their heart health,â€
he added.
Participants in the study will use an Apple Watch and Heartline Study
app, which alerts the user when the smartwatch detects an irregular
heart rhythm and advises him or her to seek advice from a healthcare
provider. The app, which also provides information and resources to the
user, can be triggered to personalize that information if a care
provider confirms an AFib diagnosis or if the user isn’t engaged with
the program.
“The decision to take action is the responsibility of the
participant, but the Heartline Study app will provide additional
prompting and educational materials to help people make informed
decisions,†Gibson said.
“I’m excited about this part of the study because, as physicians,
we need to get a better handle on how often that lack of action
happens,†he added. “While it’s clear that patients often don’t take the
medicines they’re prescribed – and, in fact, often don’t even pick them
up from the pharmacy – this study could provide more solid data and
help us learn more about how often patients don’t respond to warnings
about abnormalities in their health.â€
In time, he said, researchers hope to understand more about why
people might not take part in this type of study and develop patient
engagement techniques that promote participation and reduce barriers to
care.
Tags: EKG, mhealth, small cap stocks, stocks, tsx Posted in CardioComm Solutions | Comments Off on #Apple, #J&J Launch New #Mhealth Study Targeting #Wearables and #AFib SPONSOR: CardioComm Solutions $EKG.ca – $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca
Posted by AGORACOM-JC
at 4:56 PM on Tuesday, February 25th, 2020
SPONSOR: BetterU Education Corp.
aims to provide access to quality education from around the world. The
company plans to bridge the prevailing gap in the education and job
industry and enhance the lives of its prospective learners by developing
an integrated ecosystem. Click here for more information.
4 Reasons Why The EdTech Industry Is Set To Take Off
Education Sector is Ripe for Disruption
Increasing User Base of Mobile Phones and Internet
With the influx of smart devices, Internet and advanced software, the
scope of education is expanding to every nook and corner of India. The
impact of edtech
on not just the education sector but broadly on the society is
applaud-worthy, which is why the edtech sector is also highly popular
among aspiring start-ups.
Online learning and courses are growing at a rapid pace as
professionals realize the lack of skill-based courses and poor
infrastructure in the Indian education system is now affecting their
careers.
In the last few years, an increasing number of entrepreneurs have
also realized the potential of edtech. The uptrend will continue, thanks
to the Digital India campaign, the cultural importance of education in Indian society, and low mobile data prices.
Private equity and venture capitalfirms are also keenly
investing in this sector and not just in K–12 (kindergarten to 12th
grade) but also in online courses. Supplemental courses, test
preparation, online certification and gamification have vast potential
that is yet to be explored.
Education Sector is Ripe for Disruption
The Indian education system has been following the same traditional
approach for decades. Even though the Indian culture has always laid
high emphasis on education, yet it has seen a minimal transformation. To
reform the country into a digitally empowered nation, the Indian
government has also launched the initiative Digital India.
The education sector is ripe for disruption—ranging from government
initiatives to steps taken by educational institutions. The country is
seeing a massive wave of revolution in the edtech sector. Schools and
universities are embracing digital educational tools, and even offices
are encouraging their employees to take up online courses to be more
efficient and productive.
Increasing User Base of Mobile Phones and Internet
The penetration of smartphones and cheap data rates
has been a game-changer for the edtechs. Today, there are over 350
million mobile phone users in India, which is expected to double by
2022. With these numbers, there is no doubt that mobile phones and
digital devices are the classrooms of the future.
Online courses, virtual classrooms, digital teaching tools in
classes, and through the increasing use of cutting-edge technologies
such as virtual reality, artificial intelligence and augmented reality,
the delivery and methodology of learning is changing. Not just the
learners and educators, but entrepreneurs are becoming increasingly
aware of the potential of technology in education.
The Young Are Leading the Way
The workplaces have changed drastically, and the education system
must change along. The edtech sector is helping fill the gaps between
the education system and the professional world—it is aiding individuals
to develop practical skills in addition to the theory taught in
classrooms.
Edtech entrepreneurs, or edupreneurs,
are mostly young minds who are passionate about technology and
aspirational. They are revolutionizing the education sector by launching
unique initiatives and balancing technology with learning, helping it
reach students, teachers and parents across metros, and tier II and III
cities.
Personalization of Education
With technology, the educators (teachers, professors, and educational
institutions) will be able to strategize and customize the syllabi as
per each student. The various educational programmes today are
addressing the distinct interests, learning requirements and aspirations
of a learner structure.
Online courses are offering the masses a flexible and affordable way
to acquire new skills. The advancements in education are helping people
access education easily, rise above traditional bookish knowledge, and
gain a better understanding of a subject through videos, online study
material and educational apps with a variety of learning tools.
Education in India is yet to go a long way, but the edtech sector is overcoming the hurdles one at a time.
